Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. BeOne Medicines Ltd ADR shares valued at $23,278,679 were sold by OYLER JOHN on Dec 15 ’25. At $307.79 per share, OYLER JOHN sold 75,631 shares. The insider’s holdings dropped to 24,369 shares worth approximately $7.6 million following the completion of this transaction.
Also, OYLER JOHN sold 24,369 shares, netting a total of over 7,380,739 in proceeds. Following the sale of shares at $302.87 each, the insider now holds 0 shares.
Before that, JOHN V OYLER had added 100,000 shares to its account. In a trade valued at $31,906,000, the Director bought BeOne Medicines Ltd ADR shares for $319.06 each.
As published in their initiating research note from Truist on November 24, 2025, BeOne Medicines Ltd ADR [ONC] has been a Buy. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of April 07, 2025, RBC Capital Mkts has initiated its “an Outperform” rating for ONC. Earlier on March 03, 2025, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for ONC stock which previously was a “a Neutral”.
Analyzing ONC Stock Performance
On last trading session, BeOne Medicines Ltd ADR [NASDAQ: ONC] plunged -0.19% to $311.73. The stock’s lowest price that day was $308.16, but it reached a high of $314.46 in the same session. During the last five days, there has been a surge of approximately 1.86%. Over the course of the year, BeOne Medicines Ltd ADR shares have jumped approximately 76.62%. Shares of the company reached a 52-week high of $385.22 on 11/17/25 and a 52-week low of $172.67 on 01/08/25.
Support And Resistance Levels for BeOne Medicines Ltd ADR (ONC)
According to the 24-hour chart, there is a support level at 308.44, which, if violated, would cause prices to drop to 305.15. In the upper region, resistance lies at 314.74. The next price resistance is at 317.75. RSI (Relative Strength Index) is 41.70 on the 14-day chart, showing neutral technical sentiment.
Is BeOne Medicines Ltd ADR subject to short interest?
Stocks of BeOne Medicines Ltd ADR saw a sharp steep in short interest on 2025-11-28 dropping by 43076.0 shares to 1.52 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.57 million shares. A decline of -2.83% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.95 of the overall float, the days-to-cover ratio (short ratio) decline to 4.95.
Which companies own the most shares of BeOne Medicines Ltd ADR (ONC)?
In terms of BeOne Medicines Ltd ADR share price expectations, FactSet research, analysts set an average price target of 392.5 in the next 12 months, up nearly 25.67% from the previous closing price of $312.32. Analysts anticipate BeOne Medicines Ltd ADR stock to reach 420 by 2025, with the lowest price target being 383. On December 03, 2024, Morgan Stanley assigned a price target of “an Overweight” to the stock and resumed coverage with a $300.
